Researchers link supplement to reduced biomarkers of Alzheimer's

For the first time, a researcher at the University of Delaware College of Health Sciences in collaboration with a team at the National Institute on Aging, a division of the National Institutes of Health, has determined that the naturally occurring dietary supplement known as nicotinamide riboside (NR) can enter the brain.

JPM, Free Full-Text

NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies

Alzheimer's Biomarker Study Prompts Brain Supplement Warning

Lecanemab in Early Alzheimer's Disease

Frontiers Natural Therapeutics in Aid of Treating Alzheimer's Disease: A Green Gateway Toward Ending Quest for Treating Neurological Disorders

Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants, Alzheimer's Research & Therapy

MRI or 18F-FDG PET for Brain Age Gap Estimation: Links to Cognition, Pathology, and Alzheimer Disease Progression

Frontiers Dietary Supplements and Natural Products: An Update on Their Clinical Effectiveness and Molecular Mechanisms of Action During Accelerated Biological Aging

Natural dietary supplement successfully treats Alzheimers disease